ID   PILRA_HUMAN             Reviewed;         303 AA.
AC   Q9UKJ1; Q8NHI1;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=Paired immunoglobulin-like type 2 receptor alpha;
DE   AltName: Full=Cell surface receptor FDF03;
DE   AltName: Full=Inhibitory receptor PILR-alpha;
DE   Flags: Precursor;
GN   Name=PILRA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH PTPN6,
RP   GLYCOSYLATION, PHOSPHORYLATION, MUTAGENESIS OF TYR-269, AND VARIANT GLY-78.
RX   PubMed=10660620; DOI=10.1074/jbc.275.6.4467;
RA   Mousseau D.D., Banville D., L'Abbe D., Bouchard P., Shen S.H.;
RT   "PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing
RT   protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with
RT   the truncated counterpart PILRbeta.";
RL   J. Biol. Chem. 275:4467-4474(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 3 AND 4), FUNCTION, TISSUE
RP   SPECIFICITY, INTERACTION WITH PTPN6 AND PTPN11, GLYCOSYLATION,
RP   PHOSPHORYLATION, AND VARIANT GLY-78.
RX   PubMed=10903717; DOI=10.4049/jimmunol.165.3.1197;
RA   Fournier N., Chalus L., Durand I., Garcia E., Pin J.J., Churakova T.,
RA   Patel S., Zlot C., Gorman D., Zurawski S., Abrams J., Bates E.E.,
RA   Garrone P.;
RT   "FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is
RT   expressed by human dendritic and myeloid cells.";
RL   J. Immunol. 165:1197-1209(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLY-78.
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH HERPES SIMPLEX VIRUS 1 GLYCOPROTEIN B (MICROBIAL
RP   INFECTION), AND FUNCTION AS A CORECEPTOR FOR THE VIRUS (MICROBIAL
RP   INFECTION).
RX   PubMed=18358807; DOI=10.1016/j.cell.2008.01.043;
RA   Satoh T., Arii J., Suenaga T., Wang J., Kogure A., Uehori J., Arase N.,
RA   Shiratori I., Tanaka S., Kawaguchi Y., Spear P.G., Lanier L.L., Arase H.;
RT   "PILRalpha is a herpes simplex virus-1 entry coreceptor that associates
RT   with glycoprotein B.";
RL   Cell 132:935-944(2008).
RN   [6]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-100.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [7]
RP   FUNCTION.
RX   PubMed=21241660; DOI=10.1016/j.bbrc.2011.01.047;
RA   Kogure A., Shiratori I., Wang J., Lanier L.L., Arase H.;
RT   "PANP is a novel O-glycosylated PILRalpha ligand expressed in neural
RT   tissues.";
RL   Biochem. Biophys. Res. Commun. 405:428-433(2011).
CC   -!- FUNCTION: Paired receptors consist of highly related activating and
CC       inhibitory receptors and are widely involved in the regulation of the
CC       immune system. PILRA is thought to act as a cellular signaling
CC       inhibitory receptor by recruiting cytoplasmic phosphatases like
CC       PTPN6/SHP-1 and PTPN11/SHP-2 via their SH2 domains that block signal
CC       transduction through dephosphorylation of signaling molecules. Receptor
CC       for PIANP. {ECO:0000269|PubMed:10903717, ECO:0000269|PubMed:21241660}.
CC   -!- FUNCTION: (Microbial infection) Acts as an entry co-receptor for herpes
CC       simplex virus 1. {ECO:0000269|PubMed:18358807}.
CC   -!- SUBUNIT: Monomer. Interacts with PTPN6/SHP-1 and PTPN11/SHP-2 upon
CC       tyrosine phosphorylation. {ECO:0000269|PubMed:10660620,
CC       ECO:0000269|PubMed:10903717}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus 1
CC       glycoprotein B. {ECO:0000269|PubMed:18358807}.
CC   -!- INTERACTION:
CC       Q9UKJ1; Q5KU26: COLEC12; NbExp=2; IntAct=EBI-965833, EBI-1104680;
CC       Q9UKJ1; Q9NQX5: NPDC1; NbExp=6; IntAct=EBI-965833, EBI-748927;
CC       Q9UKJ1; P29350: PTPN6; NbExp=5; IntAct=EBI-965833, EBI-78260;
CC       Q9UKJ1; P06436: gB; Xeno; NbExp=3; IntAct=EBI-965833, EBI-1771271;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane {ECO:0000305}; Single-
CC       pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Cell membrane {ECO:0000305}; Single-
CC       pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9UKJ1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UKJ1-2; Sequence=VSP_017502;
CC       Name=3; Synonyms=FDF03-deltaTM;
CC         IsoId=Q9UKJ1-3; Sequence=VSP_017501;
CC       Name=4; Synonyms=FDF03-M14;
CC         IsoId=Q9UKJ1-4; Sequence=VSP_017500;
CC   -!- TISSUE SPECIFICITY: Predominantly detected in hemopoietic tissues and
CC       is expressed by monocytes, macrophages, and granulocytes, but not by
CC       lymphocytes. Also strongly expressed by dendritic cells (DC);
CC       preferentially by CD14+/CD1a- DC derived from CD34+ progenitors. Also
CC       expressed by CD11c+ blood and tonsil DC, but not by CD11c- DC
CC       precursors. {ECO:0000269|PubMed:10903717}.
CC   -!- DOMAIN: Contains 2 copies of a cytoplasmic motif that is referred to as
CC       the immunoreceptor tyrosine-based inhibitor motif (ITIM). This motif is
CC       involved in modulation of cellular responses. The phosphorylated ITIM
CC       motif can bind the SH2 domain of several SH2-containing phosphatases.
CC       PTPN6 seems to bind predominantly to the first ITIM motif.
CC   -!- PTM: According to PubMed:10660620, N- and O-glycosylated. According to
CC       PubMed:10903717, only N-glycosylated. {ECO:0000269|PubMed:10660620,
CC       ECO:0000269|PubMed:10903717, ECO:0000269|PubMed:19159218}.
CC   -!- PTM: Phosphorylated on tyrosine residues. {ECO:0000269|PubMed:10660620,
CC       ECO:0000269|PubMed:10903717}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF161080; AAD52964.1; -; mRNA.
DR   EMBL; AJ400841; CAC01613.1; -; mRNA.
DR   EMBL; AJ400842; CAC01614.1; -; mRNA.
DR   EMBL; AJ400843; CAC01615.1; -; mRNA.
DR   EMBL; AC005071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC017812; AAH17812.1; -; mRNA.
DR   CCDS; CCDS47660.1; -. [Q9UKJ1-4]
DR   CCDS; CCDS5691.1; -. [Q9UKJ1-1]
DR   CCDS; CCDS5692.1; -. [Q9UKJ1-3]
DR   RefSeq; NP_038467.2; NM_013439.2. [Q9UKJ1-1]
DR   RefSeq; NP_840056.1; NM_178272.1. [Q9UKJ1-3]
DR   RefSeq; NP_840057.1; NM_178273.1. [Q9UKJ1-4]
DR   PDB; 3WUZ; X-ray; 1.30 A; A=32-150.
DR   PDB; 3WV0; X-ray; 2.30 A; A/B=32-150.
DR   PDB; 4NFB; X-ray; 1.60 A; A=32-150.
DR   PDB; 5XO2; X-ray; 2.20 A; A/B=32-150.
DR   PDB; 5XOF; X-ray; 1.96 A; A/B/C/D=32-150.
DR   PDBsum; 3WUZ; -.
DR   PDBsum; 3WV0; -.
DR   PDBsum; 4NFB; -.
DR   PDBsum; 5XO2; -.
DR   PDBsum; 5XOF; -.
DR   AlphaFoldDB; Q9UKJ1; -.
DR   SMR; Q9UKJ1; -.
DR   BioGRID; 119017; 25.
DR   IntAct; Q9UKJ1; 13.
DR   STRING; 9606.ENSP00000198536; -.
DR   UniLectin; Q9UKJ1; -.
DR   GlyGen; Q9UKJ1; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UKJ1; -.
DR   PhosphoSitePlus; Q9UKJ1; -.
DR   BioMuta; PILRA; -.
DR   DMDM; 296439272; -.
DR   jPOST; Q9UKJ1; -.
DR   MassIVE; Q9UKJ1; -.
DR   PaxDb; Q9UKJ1; -.
DR   PeptideAtlas; Q9UKJ1; -.
DR   PRIDE; Q9UKJ1; -.
DR   ProteomicsDB; 84802; -. [Q9UKJ1-1]
DR   ProteomicsDB; 84803; -. [Q9UKJ1-2]
DR   ProteomicsDB; 84804; -. [Q9UKJ1-3]
DR   ProteomicsDB; 84805; -. [Q9UKJ1-4]
DR   Antibodypedia; 30692; 177 antibodies from 24 providers.
DR   DNASU; 29992; -.
DR   Ensembl; ENST00000198536.7; ENSP00000198536.2; ENSG00000085514.16. [Q9UKJ1-1]
DR   Ensembl; ENST00000350573.2; ENSP00000340109.2; ENSG00000085514.16. [Q9UKJ1-3]
DR   Ensembl; ENST00000394000.6; ENSP00000377569.2; ENSG00000085514.16. [Q9UKJ1-4]
DR   GeneID; 29992; -.
DR   KEGG; hsa:29992; -.
DR   MANE-Select; ENST00000198536.7; ENSP00000198536.2; NM_013439.3; NP_038467.2.
DR   UCSC; uc003uuo.1; human. [Q9UKJ1-1]
DR   CTD; 29992; -.
DR   DisGeNET; 29992; -.
DR   GeneCards; PILRA; -.
DR   HGNC; HGNC:20396; PILRA.
DR   HPA; ENSG00000085514; Low tissue specificity.
DR   MIM; 605341; gene.
DR   neXtProt; NX_Q9UKJ1; -.
DR   NIAGADS; ENSG00000085514; -.
DR   OpenTargets; ENSG00000085514; -.
DR   PharmGKB; PA134873007; -.
DR   VEuPathDB; HostDB:ENSG00000085514; -.
DR   eggNOG; ENOG502SUHR; Eukaryota.
DR   GeneTree; ENSGT00940000163799; -.
DR   HOGENOM; CLU_070832_0_0_1; -.
DR   InParanoid; Q9UKJ1; -.
DR   OMA; YFCRVEM; -.
DR   OrthoDB; 1325787at2759; -.
DR   PhylomeDB; Q9UKJ1; -.
DR   TreeFam; TF338478; -.
DR   PathwayCommons; Q9UKJ1; -.
DR   Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell.
DR   SignaLink; Q9UKJ1; -.
DR   BioGRID-ORCS; 29992; 25 hits in 1060 CRISPR screens.
DR   ChiTaRS; PILRA; human.
DR   GenomeRNAi; 29992; -.
DR   Pharos; Q9UKJ1; Tbio.
DR   PRO; PR:Q9UKJ1; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q9UKJ1; protein.
DR   Bgee; ENSG00000085514; Expressed in monocyte and 140 other tissues.
DR   ExpressionAtlas; Q9UKJ1; baseline and differential.
DR   Genevisible; Q9UKJ1; HS.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042288; F:MHC class I protein binding; IBA:GO_Central.
DR   GO; GO:0007165; P:signal transduction; IDA:MGI.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane; Glycoprotein;
KW   Host-virus interaction; Immunoglobulin domain; Membrane; Phosphoprotein;
KW   Receptor; Reference proteome; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..303
FT                   /note="Paired immunoglobulin-like type 2 receptor alpha"
FT                   /id="PRO_0000226821"
FT   TOPO_DOM        20..197
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        198..218
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        219..303
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          32..150
FT                   /note="Ig-like V-type"
FT   REGION          226..296
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           267..272
FT                   /note="ITIM motif 1"
FT   MOTIF           296..301
FT                   /note="ITIM motif 2"
FT   COMPBIAS        231..256
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        271..296
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        100
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         152..303
FT                   /note="AVTTTTQRPSSMTTTWRLSSTTTTTGLRVTQGKRRSDSWHISLETAVGVAVA
FT                   VTVLGIMILGLICLLRWRRRKGQQRTKATTPAREPFQNTEEPYENIRNEGQNTDPKLNP
FT                   KDDGIVYASLALSSSTSPRAPPSHRPLKSPQNETLYSVLKA -> GNPSKTQRSHMRIS
FT                   GMKDKIQIPS (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10903717"
FT                   /id="VSP_017500"
FT   VAR_SEQ         152..224
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10903717"
FT                   /id="VSP_017501"
FT   VAR_SEQ         264..303
FT                   /note="DDGIVYASLALSSSTSPRAPPSHRPLKSPQNETLYSVLKA -> LHLTQSTS
FT                   QPPSPQEPPERDPVLCLKGLTNGQPSQD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_017502"
FT   VARIANT         78
FT                   /note="R -> G (in dbSNP:rs1859788)"
FT                   /evidence="ECO:0000269|PubMed:10660620,
FT                   ECO:0000269|PubMed:10903717, ECO:0000269|PubMed:15489334"
FT                   /id="VAR_060361"
FT   VARIANT         279
FT                   /note="S -> L (in dbSNP:rs34266222)"
FT                   /id="VAR_056062"
FT   MUTAGEN         269
FT                   /note="Y->F: Greatly diminishes interaction with PTPN6."
FT                   /evidence="ECO:0000269|PubMed:10660620"
FT   CONFLICT        92
FT                   /note="D -> E (in Ref. 2; CAC01615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        281
FT                   /note="R -> K (in Ref. 1; AAD52964)"
FT                   /evidence="ECO:0000305"
FT   STRAND          34..36
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          39..44
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          49..56
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          68..77
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   TURN            84..87
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   HELIX           91..93
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:5XO2"
FT   STRAND          97..100
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          106..112
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   HELIX           117..119
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          121..131
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   TURN            132..134
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          135..140
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   STRAND          145..150
FT                   /evidence="ECO:0007829|PDB:3WUZ"
FT   CONFLICT        Q9UKJ1-4:168
FT                   /note="K -> R (in Ref. 2; CAC01615)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   303 AA;  34005 MW;  77BD068C63274A40 CRC64;
     MGRPLLLPLL PLLLPPAFLQ PSGSTGSGPS YLYGVTQPKH LSASMGGSVE IPFSFYYPWE
     LATAPDVRIS WRRGHFHRQS FYSTRPPSIH KDYVNRLFLN WTEGQKSGFL RISNLQKQDQ
     SVYFCRVELD TRSSGRQQWQ SIEGTKLSIT QAVTTTTQRP SSMTTTWRLS STTTTTGLRV
     TQGKRRSDSW HISLETAVGV AVAVTVLGIM ILGLICLLRW RRRKGQQRTK ATTPAREPFQ
     NTEEPYENIR NEGQNTDPKL NPKDDGIVYA SLALSSSTSP RAPPSHRPLK SPQNETLYSV
     LKA
//
